AbCellera Biologics Inc.
ABCL
Ранг среди акций
#4059
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the... AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Цена акции
$12.29
Последняя синхронизация: 2026-10-21
Рыночная капитализация
$3.98B
Изменение (1 день)
4.95%
Изменение (1 год)
124.68%
Страна
CA
Торговля AbCellera Biologics Inc. (ABCL)
Категория
Healthcare
История цены акций AbCellera Biologics Inc. (ABCL)
Наивысшая цена закрытия: $12.67 2026-10-01
Наименьшая цена закрытия: $45.73 2020-12-01
Наименьшая цена закрытия: $45.73 2020-12-01
История цены акций AbCellera Biologics Inc. с 2020 по 2026
Годовая динамика цены акций
| Год | Результативность |
|---|---|
| 2026 (TTM) | 69.44% |
| 2025 | 23.13% |
| 2024 | -44.83% |
| 2023 | -50.84% |
| 2022 | -25.40% |
| 2021 | -68.67% |
| 2020 | 0.00% |
Цена акций похожих компаний или конкурентов
| Компания | Цена акций | Изменение 1г% | Страна |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.77 | -3.82% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
